ORIGINAL RESEARCH article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1542024

This article is part of the Research TopicThe interaction of chronic viral infections and SARS-CoV-2 infection and its effect on the COVID-19 pathogenesisView all 9 articles

Characteristics, management and factors associated with poor outcomes in COVID-19 patients in Burkina Faso: insights from a 2021 large-scale ambispective study

Provisionally accepted
Ariane  Mamguem KamgaAriane Mamguem Kamga1*Samiratou  OuédraogoSamiratou Ouédraogo2Firmin  Nongodo KaboréFirmin Nongodo Kaboré3Isidore  Tiandiogo TraoréIsidore Tiandiogo Traoré3Esperance  OuédraogoEsperance Ouédraogo4Armel  PodaArmel Poda5Arnaud  Eric DiendéréArnaud Eric Diendéré6Dramane  KaniaDramane Kania3Hermann  BadoloHermann Badolo2Guillaume  SanouGuillaume Sanou2Amariane  KonéAmariane Koné3Therese  Samdapawindé KagonéTherese Samdapawindé Kagoné3Blahima  KonatéBlahima Konaté4Rachel  MédahRachel Médah3Nathalie  de RekeneireNathalie de Rekeneire7Boukary  OuédraogoBoukary Ouédraogo6Oumar  BillaOumar Billa1Gilles  ParadisGilles Paradis8Halidou  TintoHalidou Tinto9Tienhan  Sandrine Dabakuyo-yonliTienhan Sandrine Dabakuyo-yonli1
  • 1Centre Georges François Leclerc, Dijon, France
  • 2Institut National de Santé Publique (Burkina Faso), Ouagadougou, Burkina Faso
  • 3MURAZ Center, Bobo-Dioulasso, Burkina Faso
  • 4Centre National de la Recherche Scientifique et Technologique, Ouagadougou, Burkina Faso
  • 5COMMUNE DE BOBO DIOULASSO, Bobo-Dioulasso, Burkina Faso
  • 6Health Ministry ( Burkina Faso), Ouagadougou, Burkina Faso
  • 7Expert System France S.A., Paris, France
  • 8McGill University, Montreal, Canada
  • 9Clinical Research Unit of Nanoro (CRUN), Nanoro, Burkina Faso

The final, formatted version of the article will be published soon.

Objectives: To assess treatment and identify predictive factors of worsening in COVID-19 patients. Methods: This study was ambispective (both prospective and retrospective) and part of a multidisciplinary, multicenter project designed to generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso. Medical records of patients admitted for COVID-19 at the hospitals of Ouagadougou and Bobo-Dioulasso from March 2020 to April 2021 were reviewed. To identify predictive factors of severe complications, we used Poisson regression models.Results: In total, 1511 patients were included, of whom 70% were aged ≤50 years, 59% were men and 97% were living in an urban area. Of the 86% of patients treated, 92.9% of them received the combo Azithromycin-hydroxychloroquine. A total of 78 (5.2%) patients experienced complications during hospitalization, and 49 (3.3%) patients died. Multivariate analysis identified patient's age, residence and comorbidity as factors associated with poor outcomes.Although most people had symptoms, most of them recovered without sequelae, and few patients had severe forms of disease. Age was a strong predictor of worse outcomes in this population.

Keywords: age, Comorbidity, COVID-19, complications, Treatment

Received: 09 Dec 2024; Accepted: 13 Jun 2025.

Copyright: © 2025 Mamguem Kamga, Ouédraogo, Kaboré, Traoré, Ouédraogo, Poda, Diendéré, Kania, Badolo, Sanou, Koné, Kagoné, Konaté, Médah, de Rekeneire, Ouédraogo, Billa, Paradis, Tinto and Dabakuyo-yonli. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Ariane Mamguem Kamga, Centre Georges François Leclerc, Dijon, France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.